- Home
- ATXS vs DDD Comparison
ATXS vs DDD Comparison
Compare ATXS & DDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- DDD
- Stock Information
- Founded
- ATXS 2008
- DDD 1986
- Country
- ATXS United States
- DDD United States
- Employees
- ATXS N/A
- DDD N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- DDD Computer peripheral equipment
- Sector
- ATXS Health Care
- DDD Technology
- Exchange
- ATXS Nasdaq
- DDD Nasdaq
- Market Cap
- ATXS 401.2M
- DDD 344.6M
- IPO Year
- ATXS 2015
- DDD N/A
- Fundamental
- Price
- ATXS $4.04
- DDD $1.86
- Analyst Decision
- ATXS Strong Buy
- DDD Hold
- Analyst Count
- ATXS 5
- DDD 3
- Target Price
- ATXS $26.60
- DDD $3.50
- AVG Volume (30 Days)
- ATXS 369.7K
- DDD 3.4M
- Earning Date
- ATXS 05-08-2025
- DDD 03-26-2025
- Dividend Yield
- ATXS N/A
- DDD N/A
- EPS Growth
- ATXS N/A
- DDD N/A
- EPS
- ATXS N/A
- DDD N/A
- Revenue
- ATXS N/A
- DDD $440,121,000.00
- Revenue This Year
- ATXS N/A
- DDD N/A
- Revenue Next Year
- ATXS N/A
- DDD $5.15
- P/E Ratio
- ATXS N/A
- DDD N/A
- Revenue Growth
- ATXS N/A
- DDD N/A
- 52 Week Low
- ATXS $3.56
- DDD $1.72
- 52 Week High
- ATXS $12.92
- DDD $5.00
- Technical
- Relative Strength Index (RSI)
- ATXS 28.96
- DDD 30.44
- Support Level
- ATXS $3.56
- DDD $1.95
- Resistance Level
- ATXS $4.39
- DDD $2.13
- Average True Range (ATR)
- ATXS 0.42
- DDD 0.16
- MACD
- ATXS -0.04
- DDD 0.03
- Stochastic Oscillator
- ATXS 22.61
- DDD 24.44
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About DDD 3D Systems Corporation
3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, on-demand manufacturing services, and digital design tools. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.